1. Home
  2. LUNG vs AGD Comparison

LUNG vs AGD Comparison

Compare LUNG & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • AGD
  • Stock Information
  • Founded
  • LUNG 1995
  • AGD 2006
  • Country
  • LUNG United States
  • AGD United Kingdom
  • Employees
  • LUNG N/A
  • AGD N/A
  • Industry
  • LUNG Industrial Specialties
  • AGD Trusts Except Educational Religious and Charitable
  • Sector
  • LUNG Health Care
  • AGD Finance
  • Exchange
  • LUNG Nasdaq
  • AGD Nasdaq
  • Market Cap
  • LUNG 248.0M
  • AGD 253.4M
  • IPO Year
  • LUNG 2020
  • AGD N/A
  • Fundamental
  • Price
  • LUNG $6.45
  • AGD $10.48
  • Analyst Decision
  • LUNG Strong Buy
  • AGD
  • Analyst Count
  • LUNG 7
  • AGD 0
  • Target Price
  • LUNG $13.71
  • AGD N/A
  • AVG Volume (30 Days)
  • LUNG 210.4K
  • AGD 61.2K
  • Earning Date
  • LUNG 10-28-2024
  • AGD 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • AGD 8.13%
  • EPS Growth
  • LUNG N/A
  • AGD N/A
  • EPS
  • LUNG N/A
  • AGD N/A
  • Revenue
  • LUNG $76,583,000.00
  • AGD N/A
  • Revenue This Year
  • LUNG $22.73
  • AGD N/A
  • Revenue Next Year
  • LUNG $19.02
  • AGD N/A
  • P/E Ratio
  • LUNG N/A
  • AGD N/A
  • Revenue Growth
  • LUNG 26.26
  • AGD N/A
  • 52 Week Low
  • LUNG $5.46
  • AGD $8.20
  • 52 Week High
  • LUNG $14.84
  • AGD $9.78
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 32.80
  • AGD 58.40
  • Support Level
  • LUNG $6.56
  • AGD $10.35
  • Resistance Level
  • LUNG $7.47
  • AGD $10.52
  • Average True Range (ATR)
  • LUNG 0.38
  • AGD 0.08
  • MACD
  • LUNG -0.22
  • AGD -0.01
  • Stochastic Oscillator
  • LUNG 2.76
  • AGD 58.70

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About AGD abrdn Global Dynamic Dividend Fund of Beneficial Interest

Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current dividend income. The Fund also focuses on the long-term growth of capital as a secondary investment objective.

Share on Social Networks: